Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...
Urbanization and a warmer climate means that more people want to swim in canals, harbors, and urban beaches. However, this ...
At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow ...
A new Swedish innovation uses machine learning and laser scanning to identify contaminated water in just 20 minutes, reducing ...
BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...
Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...
Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...
Urbanisation and a warmer climate means that more people want to swim in canals, harbours, and urban beaches. However, this means that they may ...
A laser-based testing approach created by researchers at Lund University, Sweden Water Research, and Kristianstad University has been successfully tested in Helsingborg, where the test turnaround time ...
Neutrophils cause time-of-day–dependent collateral tissue damage after sterile injury through an intrinsic circadian program.
An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited activity among patients with advanced multiple myeloma, according to findings presented at ASH Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback